Ex vivo expanded autologous human corneal epithelial cells containing stem cells (Holoclar®) accepted for use within NHS Scotland on interim basis subject to ongoing evaluation and future reassessment

Holoclar is approved for treatment of adult patients with moderate to severe limbal stem cell deficiency, unilateral or bilateral, due to physical or chemical ocular burns.


Scottish Medicines Consortium